IDEAYA Biosciences, Inc.
IDYA
$40.17
$0.220.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 47.25% | 54.39% | 58.58% | 9.76% | -115.82% |
| Total Depreciation and Amortization | 11.69% | 18.48% | 19.80% | -4.18% | -4.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 105.64% | 139.26% | 213.90% | 286.97% | 318.44% |
| Change in Net Operating Assets | -6.22% | -69.09% | -83.82% | 46.69% | -23.77% |
| Cash from Operations | 61.98% | 67.47% | 71.28% | 31.68% | -124.86% |
| Capital Expenditure | 37.84% | 48.08% | 38.61% | 12.69% | 5.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.04% | 271.19% | 114.51% | 93.60% | 74.33% |
| Cash from Investing | -1.45% | 258.66% | 113.92% | 92.91% | 73.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -27.79% | -98.60% | -95.54% | -96.20% | -44.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,400.00% | -100.10% | -- | -100.00% | 33.33% |
| Cash from Financing | 14.60% | -98.64% | -95.60% | -96.27% | -43.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 331.24% | 29.05% | 139.48% | -140.81% | -185.22% |